Skip to main content
. 2017 Jan 18;12(1):e0170432. doi: 10.1371/journal.pone.0170432

Table 3. Seroprevalence of anti-HAV by sex.

2010 2011 2012 2013 2014
Age M F M F M F M F M F
0~9 61.8 65.4 45.2 56.8* 65.2 69.7 62 66.5 67.5 65.4
10~19 18.1 20 25.7 26.5 31.1 33.1 35.3 35.1 37.1 31.9*
20~29 7.9 9.6* 12.3 13.9* 15.3 16.3 14.8 17.5* 16.5 19.9*
30~39 42.6 38* 38.6 32.9* 35.6 30.4* 33.4 29.4* 31 30.5
40~49 87.2 88.4* 85.4 86.3 84 84.4 81.3 81.6 79.9 79.9
50~59 98.7 98.7 98.6 98.7 98.2 98.4 97.9 98.2 97.9 98.2
60~ 98.8 99.4 97.7 98.9* 99 99.5 99.5 99.7 99.3 99.7*
Total** 59.3 62.7 58.3 62.6 61.5 64.2 60.5 62.7 61.0 63.2

*Positivity of anti-HAV was significantly different between males and females (p < .05 by the chi-square test)

**Seroprevalence of anti-HAV was adjusted by age and area.